Thursday, January 8, 2009 - 3:12PM EST

Clinical Trials

11. Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Author
Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D;
Institution
Journal
N Engl J Med. 2008 Oct 2;359(14):1464-76. Epub 2008 Sep 8.
Abstract URL
Click here to view abstract

12. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Author
Chaturvedi N; Porta M; Klein R; Orchard T; Fuller J; Parving HH; Bilous R; Sjolie AK;
Institution
International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College Healthcare NHS Trust, London, UK.
Journal
Lancet. 2008 Oct 18;372(9647):1394-402. Epub 2008 Sep 25.
Abstract URL
Click here to view abstract

13. GAD treatment and insulin secretion in recent-onset type 1 diabetes.

Author
Ludvigsson J; Faresjo M; Hjorth M; Axelsson S; Cheramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R;
Institution
Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden. johnny.ludvigsson@lio.se
Journal
N Engl J Med. 2008 Oct 30;359(18):1909-20. Epub 2008 Oct 8.
Abstract URL
Click here to view abstract

14. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Author
Lund SS; Tarnow L; Astrup AS; Hovind P; Jacobsen PK; Alibegovic AC; Parving I; Pietraszek L; Frandsen M; Rossing P; Parving HH; Vaag AA;
Institution
Steno Diabetes Center, Gentofte, Denmark. sqrl@steno.dk
Journal
PLoS ONE. 2008;3(10):e3363. Epub 2008 Oct 9.
Abstract URL
Click here to view abstract

15. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Author
Belch J; MacCuish A; Campbell I; Cobbe S; Taylor R; Prescott R; Lee R; Bancroft J; MacEwan S; Shepherd J; Macfarlane P; Morris A; Jung R; Kelly C; Connacher A; Peden N; Jamieson A; Matthews D; Leese G; McKnight J; O'Brien I; Semple C; Petrie J; Gordon D; Pringle S; MacWalter R;
Institution
Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital, Dundee DD1 9SY. J.J.F.Belch@dundee.ac.uk
Journal
BMJ. 2008 Oct 16;337:a1840. doi: 10.1136/bmj.a1840.
Abstract URL
Click here to view abstract

16. Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study.

Author
Naughton MJ; Ruggiero AM; Lawrence JM; Imperatore G; Klingensmith GJ; Waitzfelder B; McKeown RE; Standiford DA; Liese AD; Loots B;
Institution
Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, 2000 W First St, Winston-Salem, NC 27104, USA. naughton@wfubmc.edu
Journal
Arch Pediatr Adolesc Med. 2008 Jul;162(7):649-57.
Abstract URL
Click here to view abstract

17. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.

Author
Danne T; Battelino T; Jarosz-Chobot P; Kordonouri O; Pankowska E; Ludvigsson J; Schober E; Kaprio E; Saukkonen T; Nicolino M; Tubiana-Rufi N; Klinkert C; Haberland H; Vazeou A; Madacsy L; Zangen D; Cherubini V; Rabbone I; Toni S; de Beaufort C; Bakker-van Waarde W; van den Berg N; Volkov I; Barrio R; Hanas R; Zumsteg U; Kuhlmann B; Aebi C; Schumacher U; Gschwend S; Hindmarsh P; Torres M; Shehadeh N; Phillip M;
Institution
Kinderkrankenhaus auf der Bult, Hanover, Janusz-Korczak-Allee 12, 30173 Hanover, Germany. danne@hka.de
Journal
Diabetologia. 2008 Sep;51(9):1594-601. Epub 2008 Jul 1.
Abstract URL
Click here to view abstract

18. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.

Author
Bartley PC; Bogoev M; Larsen J; Philotheou A;
Institution
Department of Medicine, University of Queensland, Australia. p.bartley@uq.edu.au
Journal
Diabet Med. 2008 Apr;25(4):442-9.
Abstract URL
Click here to view abstract

19. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.

Author
Maruyama T; Tanaka S; Shimada A; Funae O; Kasuga A; Kanatsuka A; Takei I; Yamada S; Harii N; Shimura H; Kobayashi T;
Institution
Third Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, Japan.
Journal
J Clin Endocrinol Metab. 2008 Jun;93(6):2115-21. Epub 2008 Apr 8.
Abstract URL
Click here to view abstract

20. Intensive insulin therapy in preschool-aged diabetic children: from multiple daily injections to continuous subcutaneous insulin infusion through indwelling catheters.

Author
Rabbone I; Bobbio A; Di Gianni V; Sacchetti C; Cerutti F;
Institution
Department of Paediatrics, University of Turin, 10126 Turin, Italy. ivana.rabbone@unito.it
Journal
J Endocrinol Invest. 2008 Mar;31(3):193-5.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4